Life Sciences VCLink’s Post

Top 5 Indian Biotech Startups - Success Stories To Inspire You! 🤩 #biotech #startups #biotechnology #lifescience #beststartups #topstartups #biology #science #india #biotechindustry #biotechsector

Laurus Bio Secures INR 160 Cr #Investment to Boost Biomanufacturing🧬 Nikita Saha writes ✍️, Eight Roads Ventures and F-Prime Capital are investing INR 120 Cr in Laurus Bio, with an additional INR 40 Cr co-investment from Laurus Labs Limited. 💼 This strategic #funding will fuel the expansion of animal-origin-free recombinant protein manufacturing, strengthening microbial fermentation capabilities. 🌐 With this, Laurus Labs retains a 75% majority stake, paving the way for global leadership in #biomanufacturing. Key leaders highlight this #partnership's potential to accelerate R&D and manufacturing growth.🚀 🔗Read More - https://lnkd.in/dMdNVy6t 🌐Stay Informed with our Latest Stories – https://lnkd.in/gMUPB2Zp #LaurusBio #EightRoadsVentures #Biomanufacturing #Innovation #FPrimeCapital #LaurusLabs #Growth

Integrated Biosciences Secures $17.2 Million to Develop Medicines for Age-Related Diseases Integrated Biosciences, Inc., a California-based biotechnology startup pioneering medicines targeting age-related illnesses, has secured $17.2 million in seed funding to advance treatment for healthier aging. Co-founded in September 2022 by Felix Wong and Max Wilson, the company develops cellular rejuvenation therapies using a combination of small molecules and optogenetics. The seed round was backed by a consortium of companies spearheaded by Sutter Hill Ventures, with significant contributions from notable investors, including Root Ventures, llumina Ventures Labs, Civilization Ventures, Lifespan Vision Ventures, SH funds (Sabrina Hahn), Overlap Holdings, Conscience VC, Reinforced Ventures, Mission BioCapital, Polymath Capital, Vijay Pandurangan and Michael Stoppelman. Read more: https://lnkd.in/gWHvZu5M #fundingnews #FundingOpportunity #StartupFunding #StartupSuccess #HealthcareNews #Biotechnology #HealthcareFunding #nextdigitalhealth #Wi4 #vineetagrawal

STARTUP-TRACKER: East Ocyon Bio Private Limited has announced the successful closure of its $4.2M seed round. The investment round was led by Aeravti Ventures and Micro Labs Limited. Click to read: https://lnkd.in/dyZJuEuu #startup #investment #biopharma #biotech #allogeneic #celltherapy #genetherapy #startup #biovoicenews

TIERRA BIO RAISES $11.4 MILLION TO EXPAND DESIGNER PROTEIN-TO-ORDER PLATFORM Tierra Biosciences, a pioneering startup in California, which specialises in AI-driven cell-free technology for streamlined custom protein synthesis has successfully raised $11.4 million in investment. Material Impact led the round, building upon Tierra Biosciences’ previous financial achievements, which include $6 million in seed funding and over $7 million in grant funding. Notable investors participating in this round include Prosus Ventures, lIn-Q-Tel (IQT), Hillspire, FreeFlow Ventures, Creative Ventures, and Social Capital, indicating widespread confidence in Tierra Biosciences’ innovative approach and promising future prospects. The CEO Michael Nemzek highlights the inefficiencies of traditional protein engineering and emphasises Tierra’s rapid and scalable approach. Tierra’s platform enables customers to order custom proteins online, leveraging AI to optimise biosynthesis methods, with plans to use the funding to enhance the platform and grow its team. To read the complete article click on this link below 👇 https://lnkd.in/eKHunNru #agritech #agritechnology #agritechinnovation

🌟 𝑺𝒑𝒐𝒕𝒍𝒊𝒈𝒉𝒕 𝒐𝒏 𝑰𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏: 𝑽𝑰𝑩 𝑩𝒊𝒐-𝑰𝒏𝒄𝒖𝒃𝒂𝒕𝒐𝒓 𝒂𝒏𝒅 272𝑩𝒊𝒐 🌟 At Flanders Investment & Trade (FIT) in the UK, we are dedicated to fostering strong trade relationships and promoting the vibrant ecosystem between the UK and Flanders. Today, we are thrilled to highlight the VIB 𝗕𝗶𝗼-𝗜𝗻𝗰𝘂𝗯𝗮𝘁𝗼𝗿, a cornerstone of innovation in Flanders. It is designed to 𝑠𝑢𝑝𝑝𝑜𝑟𝑡 𝑏𝑖𝑜𝑡𝑒𝑐ℎ 𝑠𝑡𝑎𝑟𝑡𝑢𝑝𝑠, 𝑠𝑝𝑖𝑛-𝑜𝑓𝑓𝑠, 𝑎𝑛𝑑 𝑖𝑛𝑡𝑒𝑟𝑛𝑎𝑡𝑖𝑜𝑛𝑎𝑙 𝑐𝑜𝑚𝑝𝑎𝑛𝑖𝑒𝑠. With state-of-the-art lab and office spaces, the incubator fosters collaboration and sustainable practices. The incubator’s strategic location near the Ghent University ensures a concentration of knowledge and expertise, making it an ideal launchpad for biotech ventures. One of the pioneering companies at VIB is 272BIO Limited, a UK-based firm and one of its founding tenants. 272BIO Limited focuses on applying Single Domain Antibodies in veterinary medicine, with R&D in England and production in Ghent, Flanders. Karine Clauwaert from 272BIO Limited shared her insights on why 𝗙𝗹𝗮𝗻𝗱𝗲𝗿𝘀 𝗶𝘀 𝘁𝗵𝗲 𝗶𝗱𝗲𝗮𝗹 𝗹𝗼𝗰𝗮𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝘁𝗵𝗲𝗶𝗿 𝗼𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀: "𝘍𝘭𝘢𝘯𝘥𝘦𝘳𝘴 𝘪𝘴 𝘵𝘳𝘶𝘭𝘺 𝘢𝘵 𝘵𝘩𝘦 𝘧𝘰𝘳𝘦𝘧𝘳𝘰𝘯𝘵 𝘰𝘧 𝘢𝘯𝘵𝘪𝘣𝘰𝘥𝘺 𝘳𝘦𝘴𝘦𝘢𝘳𝘤𝘩, 𝘢𝘯𝘥 𝘵𝘩𝘦𝘳𝘦 𝘪𝘴 𝘢 𝘭𝘰𝘵 𝘰𝘧 𝘦𝘹𝘱𝘦𝘳𝘵𝘪𝘴𝘦 𝘵𝘰 𝘣𝘦 𝘧𝘰𝘶𝘯𝘥 𝘩𝘦𝘳𝘦. 𝘖𝘶𝘳 𝘨𝘰𝘢𝘭 𝘪𝘴 𝘵𝘰 𝘴𝘵𝘢𝘳𝘵 𝘢 𝘴𝘮𝘢𝘭𝘭 𝘱𝘳𝘰𝘥𝘶𝘤𝘵𝘪𝘰𝘯 𝘶𝘯𝘪𝘵 𝘧𝘰𝘳 𝘱𝘳𝘰𝘰𝘧-𝘰𝘧-𝘤𝘰𝘯𝘤𝘦𝘱𝘵𝘴 𝘪𝘯 𝘵𝘩𝘦 𝘣𝘪𝘰-𝘪𝘯𝘤𝘶𝘣𝘢𝘵𝘰𝘳 𝘪𝘯 𝘎𝘩𝘦𝘯𝘵". She also highlighted the unique ecosystem, stating, "VIB 𝘱𝘭𝘢𝘺𝘦𝘥 𝘢 𝘬𝘦𝘺 𝘳𝘰𝘭𝘦 𝘪𝘯 𝘵𝘩𝘦 𝘧𝘰𝘶𝘯𝘥𝘢𝘵𝘪𝘰𝘯 𝘰𝘧 Ablynx, 𝘸𝘩𝘪𝘤𝘩 𝘪𝘴 𝘢 𝘨𝘭𝘰𝘣𝘢𝘭 𝘱𝘭𝘢𝘺𝘦𝘳 𝘪𝘯 𝘵𝘩𝘦 𝘧𝘪𝘦𝘭𝘥 𝘰𝘧 𝘢𝘯𝘵𝘪𝘣𝘰𝘥𝘺 𝘳𝘦𝘴𝘦𝘢𝘳𝘤𝘩. 𝘈𝘥𝘥𝘪𝘵𝘪𝘰𝘯𝘢𝘭𝘭𝘺, 𝘵𝘩𝘦𝘳𝘦’𝘴 𝘵𝘩𝘦 𝘱𝘳𝘰𝘹𝘪𝘮𝘪𝘵𝘺 𝘵𝘰 𝘵𝘩𝘦 𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺 𝘱𝘢𝘳𝘬. 𝘛𝘩𝘪𝘴 𝘮𝘦𝘢𝘯𝘴 𝘵𝘩𝘢𝘵 𝘢 𝘭𝘰𝘵 𝘰𝘧 𝘦𝘴𝘴𝘦𝘯𝘵𝘪𝘢𝘭 𝘬𝘯𝘰𝘸𝘭𝘦𝘥𝘨𝘦 𝘪𝘴 𝘤𝘭𝘶𝘴𝘵𝘦𝘳𝘦𝘥 𝘪𝘯 𝘰𝘯𝘦 𝘭𝘰𝘤𝘢𝘵𝘪𝘰𝘯. 𝘛𝘩𝘪𝘴 𝘤𝘳𝘦𝘢𝘵𝘦𝘴 𝘢 𝘱𝘦𝘳𝘧𝘦𝘤𝘵 𝘦𝘤𝘰𝘴𝘺𝘴𝘵𝘦𝘮, 𝘸𝘩𝘪𝘤𝘩 𝘪𝘴 𝘤𝘳𝘶𝘤𝘪𝘢𝘭 𝘧𝘰𝘳 𝘢 𝘤𝘰𝘮𝘱𝘢𝘯𝘺". 🔗 https://lnkd.in/dtjTH83g  

🚀 Atlas Venture Raises $450M to Power the Next Wave of Biotech Innovation! 🧬💡 Massachusetts-based Atlas Venture has announced its fourteenth fund with an impressive $450M, mirroring the size of its previous fund in 2022. Over the past two years, Atlas has launched 16 new biotech companies, partnered with 100+ executive leaders, and celebrated major wins, including: 🔹 Eli Lilly and Company's acquisition of Versanis Bio 🔹 GSK's $1B buyout of Aiolos Bio 🔹 Novartis' $1B deal for Mariana Oncology 🧪 Notable IPOs: Disc Medicine, Korro Bio, Inc. , Q32 Bio Inc. , and Third Harmonic Bio have taken the leap to go public, showcasing the firm’s robust portfolio and venture creation strategy. Atlas emphasises its “disciplined, focused approach”, building biotechs across disease areas, modalities, and business models while maintaining strong partnerships with supportive limited partners (LPs). 🔬 The latest addition to its portfolio? Trace Neuroscience, with $101M in Series A funding, aiming to revolutionise genomic medicine for ALS. In a biotech market buzzing with activity, Atlas joins other major players like Bain Capital and ARCH Venture Partners, who recently launched multi-billion-dollar healthcare funds. 🌐 #BiotechFunding #VentureCapital #Innovation #LifeSciences #AtlasVenture #HealthcareInvesting

💰BIO Roundup: Deal-Making Tips And Tricks • WHO SHOULD READ THIS? BD&L professionals in small companies looking for larger partners or investors. • WHAT IS IT? A round-up of insights gathered by Citeline News & Insights reporters from panel discussions and in exclusive interviews at the BIO International Conference on the subject of deal-making. • WHY IS IT IMPORTANT? Biotech companies are competing for the attention of potential partners to fund their R&D and help them achieve commercial success. This feature highlights key advice on decision-making, ranging from pipeline strategy to approaching international markets. Citeline Citeline Commercial #BIO2024

#Funding #UKStartups New Wave Biotech raises €1.2 million to transform R&D in synbio and alt protein production: London-based AI bioprocess simulation software startup New Wave Biotech has raised €1.2 million in its latest funding round through a mix of equity and grant funding to expand its existing team and explore new markets and customers. Investors include EIT Food (supported by the European Institute of Innovation and Technology) and Innovate UK (part of […] The post New Wave Biotech raises €1.2 million to transform R&D in synbio and alt protein production appeared first on EU-Startups.

📣 Application call for our early-stage startups in drug development and delivery! 🗓️ Hand in your pitch deck until June 16, 2024 All details in the post below. #startups #entrepreneurship #lifesciences